SUMMARY The heights of 33 consecutively selected mothers of children in hospital for treatment of congenital dislocation of the hip (CDH) were compared with the heights of 54 mothers of children in hospital for conditions other than CDH. The mothers of the CDH children were found to be shorter than those of the control group by a mean of 4 4 cm. This difference was statistically significant. Short maternal stature is associated with a narrow pelvis and presumably also with reduced uterine size which may cause restriction of space for the fetus.
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The aetiology of congenital dislocation of the hip (CDH) has been the subject of numerous investigations and is still considered multifactorial. Several mechanical factors have been noted to correlate with CDH-such as breech presentation,' increased birthweight and length,2 and a greater number of labours with fetopelvic disproportion.' 2A restriction of space for the fetus in utero has also been suggested.3
Since maternal factors play an important role in affecting the available space for the fetus in utero and in view of the clinical observation that several mothers of children with CDH were short, we decided to investigate the association between maternal height and CDH.
Patients and methods
The subjects of this study were 33 infants and children with clinical and radiological evidence of CDH who had been consecutively admitted to our hospital during the period 1 January to 3 June 1981 with their mothers. Each patient had been examined and diagnosed as having CDH by a senior orthopaedic surgeon and was in hospital for traction or surgical correction of the condition. There were 7 (21 %) boys and 26 (79 %) girls. Thirty-one had been vertex presentations and 2 breech presentations at birth. The ages of the mothers ranged between 19 and 35 (mean of 26-3) years.
The control group comprised 54 infants and children who had been in hospital consecutively in the paediatric department between 1 April and 10 May 1981 with their mothers. Any patient who had CDH himself or in a sibling was excluded from the control group. The referral pattern of children with CDH was similar to that of other children.
The ethnic composition of the mothers in both groups is given in the Table. The height of each mother in each group was measured, and the difference between the mean heights of the two groups was assessed by the Student's t test.
Results
Maternal height. The height of the mothers of the She was the third child of healthy, intelligent parents. Pregnancy and delivery had been normal, as had been the neonatal period. Birthweight was 3200 g and length 50 cm. Growth to age 1 year had apparently been normal but retardation of growth was noticed at 2-3 years of age.
Her parents were not related, but her maternal grandparents were consanguineous. There was no family history of thyroid disease, dwarfism, or mental abnormality.
Physical examinations showed height 93 .0 cm (-2.0 SD of the mean height for Japanese girls as reported by the Japanese Ministry of Health and Welfare), weight 13-0 kg (-1 .6 SD), with normal body proportions. The thyroid gland was not enlarged, and the remainder of the physical examination was normal. Roentgenograms of the skull were normal and bone age was 23 years.
Haematological studies, urine analysis, and blood chemical determinations were normal. An electroencephalogram was normal. Computerised tomography scans of the skull were normal. Her developmental quotient was estimated to be 112.
At the initial visit, the serum thyroxine (T4) value was 4.1 ,ug/l00ml (52.8 nmol/l) (normal 4-5-13 5 ,ug/100 ml), serum tri-iodothyronine (T3) 177 ng/ 100 ml (2-7 nmol/l) (normal 98-202 ng/100 ml), and serum TSH 14 FU/ml (normal <2-8). Thyroid uptake of 1231 sodium iodide was 7-1 % at 24 hours (normal 10-40%). A thyroid scan gave normal results. Tests for antithyroglobulin antibody and antimicrosome antibody were negative. The serum thyroxine binding globulin determined by radioimmunoassay was 20.3 ,ug/ml (338.3 nmol/l) (normal 15.7-43.3 ,ug/ml).
A peak TSH level of 70 ,uU/ml was obtained after administration of 130 ,ug (10 ,ug/kg) of TRH intravenously (normal 10-40 FU/ml). Two additional TRH tests showed similar positive responses. Luteinising hormone and follicle-stimulating hormone showed normal responses to intravenous injection of 40 jg of luteinising hormone-releasing hormone. Serum growth hormone was demonstrable in the fasting state (3 -2 ng/ml), and an increase was obtained during insulin-induced hypoglycaemia (20.5 ng/ml). The plasma level of adrenocorticotrophin was 16 pg/ml (normal I5-85) in the early morning and a peak level of 27 pg/ml was obtained by insulin-induced hypoglycaemia. Urinary 
